Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
FDA Panel Recommends Pfizer & Moderna COVID Jabs for Young Kids
12:30pm, Thursday, 16'th Jun 2022 Zacks Investment Research
The FDA VRBPAC committee unanimously recommends the approval of both Pfizer and BioNTech and Moderna's vaccines for young children, saying the benefits of the vaccines outweigh the risks.
Pfizer says Paxlovid doesn't help COVID-19 patients unless they are high risk
12:21pm, Thursday, 16'th Jun 2022 MarketWatch
The COVID-19 antiviral isn’t effective for people who are vaccinated and healthy.
FDA committee recommends two COVID-19 vaccines for young children
12:19pm, Thursday, 16'th Jun 2022 MarketWatch
The Food and Drug Administration is now expected to authorize two COVID-19 vaccines for children as young as six months old.
Pfizer (PFE) Starts EU Submission of Variant-Adapted Vaccine
12:11pm, Thursday, 16'th Jun 2022 Zacks Investment Research
Pfizer (PFE) and its partner BioNTech initiate rolling submission, seeking authorization of the variant-adapted version of their COVID-19 vaccine.
Does This FDA Panel Vote Make Moderna a Buy?
11:35am, Thursday, 16'th Jun 2022 The Motley Fool
It could open a up a whole new market for Moderna's COVID-19 vaccine.
Pfizer (PFE) COVID Pill Ineffective in Standard Risk Patients
07:22pm, Wednesday, 15'th Jun 2022 Zacks Investment Research
Pfizer (PFE) stops enrolling patients in a phase II/III study evaluating its COVID pill in standard-risk population after new data from this study showed that it is not all statistically significant.
FDA panel reviews vaccines for children under 5, and WHO warns against pandemic complacency
05:51pm, Wednesday, 15'th Jun 2022 MarketWatch
A day after a panel of advisers to the Food and Drug Administration endorsed a second brand of COVID-19 vaccine for school-age children and teens, the same panel will reconvene to discuss vaccines for
Moderna's (MRNA) COVID-19 Vaccine Nears EUA in Pediatrics
11:43am, Wednesday, 15'th Jun 2022 Zacks Investment Research
An FDA advisory committee voted in favor of the use of Moderna's (MRNA) COVID-19 vaccine in individuals aged 6 years to 17 years. A meeting to discuss the use of the vaccine in the younger population
Penny Stocks To Buy? 3 Reddit Stocks To Watch Now
02:29am, Wednesday, 15'th Jun 2022 PennyStocks
Penny Stocks To Watch Now
The post Penny Stocks To Buy? 3 Reddit Stocks To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Pfizer (PFE) Gains As Market Dips: What You Should Know
09:45pm, Tuesday, 14'th Jun 2022 Zacks Investment Research
Pfizer (PFE) closed the most recent trading day at $47.92, moving +0.02% from the previous trading session.
FDA panel to review Moderna vaccine in children aged 6 to 17, and Rolling Stones front man Mick Jagger tests positive for COVID
05:36pm, Tuesday, 14'th Jun 2022 MarketWatch
An independent panel of advisers to the Food and Drug Administration will meet later Tuesday to discuss the use of the Moderna vaccine in children aged 6 to 17.
Valneva (VALN) Down on its COVID-19 Vaccine Update in Europe
04:25pm, Tuesday, 14'th Jun 2022 Zacks Investment Research
Valneva (VALN) slides on a proposed remediation plan update after receiving the European Commission's notice of intent to terminate the Advance Purchase Agreement for its COVID-19 vaccine.
MorphoSys (MOR) Gains on Oncology Collaboration With Pfizer
03:00pm, Tuesday, 14'th Jun 2022 Zacks Investment Research
MorphoSys (MOR) and Pfizer collaborate to develop a combination of MOR's Monjuvi and Pfizer's checkpoint inhibitor candidate, TTI-622, for treating r/r DLBCL.
Lilly (LLY), Incyte's Olumiant Gets FDA Nod for Alopecia Areata
02:41pm, Tuesday, 14'th Jun 2022 Zacks Investment Research
Lilly (LLY) and Incyte's Olumiant is the first-ever FDA-approved systemic treatment for alopecia areata patients.
FDA panel to review Moderna vaccine in children aged 6 to 17, and Rolling Stones front man Mick Jagger tests positive for COVID
02:02pm, Tuesday, 14'th Jun 2022 MarketWatch
An independent panel of advisers to the Food and Drug Administration will meet later Tuesday to discuss the use of the Moderna vaccine in children aged 6 to 17.
